Pharmacological treatment profiles in the FACE-BD cohort: Treatment description and complete data for bipolar subtypes

Data in Brief

Ludovic Samalin¹  Caroline Dubertret²  Ophelia Godin³  Marion Leboyer³  Jean-Luc Bosson⁴  Frank Bellivier⁴  Raymund Schwan⁵  Valerie Aubin⁶  Paul Roux⁷  Philippe Courtet⁸  Emilie Olié⁸  Sebastien Gard⁹  Bruno Aouizerate⁹  Raoul Belzeaux^1,10  Sébastien Brodeur^1,11  Thierry Bougerol^1,11  Arnaud Pouchon^1,11  Bruno Etain^1,12  Emmanuel Haffen^1,13  Mircea Polosan^1,14  Hugo Terrisse^1,14  Chantal Henry^1,15 

[1] Service de Psychiatrie,  Le Chesnay, France;AHPH, Departement de Psychiatrie, Hopital Louis Mourier, C. Dubertret, N. Mazer, C. Portalier, Colombes, France;AP-HP, DHU PePSY, Pôle de Psychiatrie et d'Addictologie des Hôpitaux Universitaires H Mondor, Créteil, S. Hotier, A. Pelletier, N. Drancourt, JP. Sanchez, E. Saliou, C. Hebbache, J. Petrucci, L. Willaume and E. Bourdin, France;AP-HP, GH Saint-Louis–Lariboisière–Fernand Widal, Pôle Neurosciences, F. Bellivier, M. Carminati, B. Etain, E. Marlinge, M. Meyrel, Paris,  France;CHU de Clermont Ferrand, Pôle de Psychiatrie, Clermont Ferrand: Service de Psychiatrie de l'adulte B, Centre Expert Trouble Bipolaire, CHU de Clermont-Ferrand, PM. Llorca, L. Samalin, L., C. Moreau, D. Lacelle, S.Pires, C. Doriat, and O. Blanc, Clermont-Ferrand, France;Centre Hospitalier Princesse Grace, V. Aubin, I. Cussac, M.A Dupont, J. Loftus, and I. Medecin, Monaco, France;Centre Hospitalier de Versailles, Service Universitaire de Psychiatrie d'adultes, A. M. Galliot, I. Grévin, A. S. Cannavo, N. Kayser, C. Passerieux, and P. Roux;Département d'Urgence et Post Urgence Psychiatrique, CHRU Montpellier, C. Abettan, L. Bardin, A. Cazals, P. Courtet, B. Deffinis, D. Ducasse, M. Gachet, A. Henrion, E. Martinerie, F. Molière, B. Noisette, E. Olié and G. Tarquini, Montpellier,  France;Hôpital C. Perrens, Centre Expert Trouble Bipolaire, Service de Psychiatrie Adulte, Pôle 3-4-7, B. Antoniol, A. Desage, S. Gard, A. Jutant, K. Mbailara, I. Minois, and L. Zanouy, Bordeaux,  France;Pôle de Psychiatrie, addictologie et pédopsychiatrie, Hôpital Sainte Marguerite, R. Belzeaux, N. Correard, F. Groppi, A. Lefrere, L. Lescalier., E. Moreau, J. Pastol, M. Rebattu, B. Roux and N. Viglianese, Marseille,  France;Service Universitaire de Psychiatrie, CHU de Grenoble et des Alpes, T. Bougerol, B. Fredembach, A. Suisse, S. Brodeur, A. Pouchon, and M. Polosan,  Grenoble, France;Service de Psychiatrie et Psychologie Clinique, CHU de Nancy, Hôpitaux de Brabois, R. Cohen, Raymond Schwan, J. P. Kahn, M. Milazzo, and O. Wajsbrot-Elgrabli, Vandœuvre Les Nancy,  France;Service de psychiatrie, CHU de Besançon, Laboratoire de Neurosciences, Université de Franche-Comté,  E. Haffen, France;TIMC-IMAG, University Grenoble Alpes, France;Université Paris Descartes, Pôle Hospitalo-Universitaire Paris 15ème, GHU, Centre Hospitalier Sainte Anne, France;

关键词: Data set;    Clusters;    Hierarchical agglomerative clustering;    Bipolar disorders;    Machine learning;   

DOI  :  

来源: DOAJ

【 摘 要 】

In the current study, we provide the list of pharmacological interventions applied during the one-year follow-up period of the Pharmacological treatment profiles in the FACE-BD cohort study. These data show the treatments used in the new clusters formed in this previous study and also in usual bipolarity subtypes. The proportion of each treatment used during the follow-up was calculated. Days on each treatment were also included in this dataset. The complete clinical and paraclinical data analyzed for clusters and bipolar subtypes were included in this dataset. Socio-demographic self-administered and clinician-administered scales, clinical evaluation during the follow-up, psychiatric and somatic comorbidities, and blood tests are shown in this material.

【 授权许可】

Unknown